Clinical Trial Update: Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 dose-ranging study evaluating AMG 133 for overweight or obesity, with or without Type 2 Diabetes Mellitus, condu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• AMG 133

Snippet

Sponsor: Amgen | Conditions: Obesity, Overweight | Phase 2 | Status: COMPLETED